Exploring AddLife AB (publ) Investor Profile: Who’s Buying and Why?

Who is placing big bets on AddLife AB and why do the numbers matter - as of March 31, 2025 institutional investors held a commanding 82.2% of the shares, led by SEB Fonder with a concentrated 12.3% stake, while foreign investors accounted for 36.4% of capital and Swedish legal entities held 51.9%, all against a market backdrop where AddLife's market capitalisation stood at SEK 16,812 million (Dec 31, 2024) and the share price climbed 26% during the financial year - figures that sit alongside concentrated control (the ten largest shareholders control 54.9% of capital and 64.9% of votes), significant voting influence from RoosGruppen AB and Tom Hedelius, insider ownership of 8.89%, average daily trading volume of 127,322 shares (≈SEK 16 million), and a proposed SEK 0.75 per-share dividend for 2024 - all the data that explains why institutional confidence, retail participation, and international interest are converging on AddLife's strategy and stock; read on to unpack who's buying, how voting power could shape decisions, and what the market signals mean for future investor behaviour.

AddLife AB (0REZ.L) - Who Invests in AddLife AB (0REZ.L) and Why?

• Institutional investors (82.2%): Seek stable cash flows, defensive exposure to healthcare cycles, and scale benefits from AddLife's diversified product and service mix.
• Largest institutional shareholder - SEB Fonder (12.3%): Positions for portfolio diversification into Nordic healthcare infrastructure and predictable earnings growth.
• Foreign investors (36.4%): Attracted by international growth potential and cross-border distribution capabilities; significant capital originates from the USA, Norway, and Luxembourg.
• Swedish legal entities (51.9%): Insurance companies and domestic funds favor AddLife for local market leadership and regulatory familiarity.
• Individual insiders (8.89%): Management and board members hold meaningful stakes, aligning interests with shareholders and signaling confidence in long-term strategy.
• General public (6.66%): Retail participation provides market breadth but remains secondary to institutional ownership.

• Why institutional investors persist: predictable demand for lab suppliers and diagnostic products, recurring consumable revenues, and M&A-driven scale gains that improve margins.
• Why foreign investors participate: international distribution channels, exposure to Nordic healthcare stability, and potential for cross-border expansion.
• Why insiders hold meaningful positions: alignment of management incentives with shareholder returns, insider conviction in organic and acquisitive growth plans.

AddLife AB (0REZ.L) Institutional Ownership and Major Shareholders of AddLife AB (0REZ.L)

• Concentrated voting power: Major shareholders (notably RoosGruppen and Tom Hedelius) hold a disproportionately high share of votes relative to capital, which can decisively shape board composition, strategic approvals and M&A outcomes.
• Institutional presence: SEB Fonder, AMF Fonder and Odin Fonder are among the largest institutional investors, collectively providing long-term capital, governance pressure and access to market expertise.
• Mixed investor base: The blend of Swedish domestic funds and foreign/international investors supports diversified capital-raising options and signals cross-border investor confidence.
• Corporate governance implications: With 64.9% of voting rights concentrated among the top ten, active shareholder relations, targeted communication and institutional engagement become critical for management to secure support for strategic initiatives.
• Strategic benefits: Major institutional holders can offer AddLife strategic guidance, network access and potential partnership channels that may enhance competitiveness and support execution of growth plans.

AddLife AB (0REZ.L) - Key Investors and Their Impact on AddLife AB (0REZ.L)

AddLife AB's shareholder base shows concentrated voting influence among a few large holders while capital ownership is more distributed. The following table summarizes the principal investors highlighted and their reported voting power and capital stakes, with inferred implications for governance and strategy.

• RoosGruppen AB (16.1% votes / 4.9% capital): May use disproportionate voting leverage to steer major decisions (M&A approvals, board votes, corporate strategy) while remaining a modest capital holder - a governance dynamic that requires management to balance strategic concessions with broader shareholder interests.
• Tom Hedelius (12.7% votes / 1.7% capital): Individual influence in AGMs and nomination processes; potential catalyst for governance reforms or targeted strategic initiatives if aligned with other large voters.
• SEB Fonder (12.3% stake): Large institutional equity holder showing conviction in AddLife's growth prospects; likely to engage on operational performance, capital allocation, and returns metrics.

• AMF Fonder (8.9%): Pension fund-style investor favoring steady, long-term value creation - supportive of policies that enhance resilience and predictable cash flows.
• Odin Fonder (6.9%): Active Nordic asset manager with a growth-oriented view; can influence expectations around market positioning, innovation investments, and ESG-linked governance.
• Collective effect: With the top five controlling 56.9% of votes and ~35% of capital, coordinated positions among them could effectively determine board elections, approve strategic transactions, or block proposals that conflict with their priorities.

Practical implications for management and investor relations include prioritizing transparent communication on strategic roadmaps, demonstrating alignment between capital deployment and shareholder return metrics, and proactively engaging the largest holders to mitigate activism or voting surprises. For a corporate overview tied to stated direction and values, see Mission Statement, Vision, & Core Values (2026) of AddLife AB (publ).

AddLife AB (0REZ.L) - Market Impact and Investor Sentiment

• Market capitalization: SEK 16,812 million (as of December 31, 2024).
• Share price change: +26% during the financial year, versus OMX Stockholm index: +6%.
• Annual high / low: SEK 168.00 (June 5, 2024) - SEK 94.85 (October 25, 2024), indicating intra-year volatility and responsiveness to news flow.
• Average daily trading volume: 127,322 shares (approx. SEK 16 million in value per trading day).
• Average trades per day: 807, reflecting steady retail and institutional engagement.
• Proposed dividend (FY2024): SEK 0.75 per share; implied payout ratio ≈ 30-50% of profit after tax, attractive to income-oriented investors.

• Investor sentiment drivers: above-index share outperformance, consistent liquidity, dividend policy supporting yield-seeking buyers, and visible intra-year volatility attracting active traders and momentum funds.
• Market impact considerations: market cap and turnover support inclusion in institutional watchlists; the 26% price appreciation signals re-rating potential for valuation-sensitive investors.
• Risks to sentiment: the pronounced high/low spread in 2024 underscores sensitivity to earnings releases, acquisition/news flow and macro conditions.